James Hoffman, based in Ardmore, PA, US, is currently a Director, CMC Regulatory Affairs, Gene and Cell Therapy at Poseida Therapeutics, Inc., bringing experience from previous roles at Amicus Therapeutics, United States Food & Drug Administration, Sapientia Pharmaceuticals and GlaxoSmithKline. James Hoffman holds a 1989 - 1991 MBA in Marketing @ Saint Joseph's University. With a robust skill set that includes Data Mining, Intellectual Property, Process Improvement, Change Management, Predictive Modeling and more, James Hoffman contributes valuable insights to the industry. James Hoffman has 4 emails on RocketReach.